VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,713 | -10.5% | 14,928 | +0.2% | 0.04% | -7.3% |
| Q2 2023 | $448,760 | -11.4% | 14,904 | -4.8% | 0.04% | -12.8% |
| Q1 2023 | $506,310 | -94.1% | 15,651 | -94.7% | 0.05% | -93.5% |
| Q4 2022 | $8,531,109 | +2139.1% | 297,666 | +1784.9% | 0.72% | +1794.7% |
| Q3 2022 | $381,000 | +0.8% | 15,792 | +14.5% | 0.04% | +15.2% |
| Q2 2022 | $378,000 | -27.9% | 13,795 | +1.0% | 0.03% | -17.5% |
| Q1 2022 | $524,000 | +64.3% | 13,655 | +37.2% | 0.04% | +73.9% |
| Q4 2021 | $319,000 | -10.4% | 9,951 | -17.7% | 0.02% | -17.9% |
| Q3 2021 | $356,000 | -13.4% | 12,093 | 0.0% | 0.03% | -9.7% |
| Q2 2021 | $411,000 | +1.2% | 12,093 | -3.1% | 0.03% | -3.1% |
| Q1 2021 | $406,000 | -94.7% | 12,486 | -94.1% | 0.03% | -95.0% |
| Q4 2020 | $7,626,000 | – | 211,711 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |